The In-vivo toxicology market was valued at USD 5.3 billion in 2021 and projected to reach USD 8.2 billion by 2030, growing at a CAGR of 6.10% during the forecast period, 2022-2030.

The significant factors are the growing demand for toxicology testing during drug development at an early stage and increasing R&D investments.

Major market player included in this report are:
Danaher
Thermo Fisher Scientific
Charles River
Covance
The Jackson Laboratory
Taconic Biosciences Inc
Eurofins Scientific
Envigoand Dynamic Systems Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product & Services
Consumables
Reagents and Kits
Animal Models
Instruments
By Testing Type
Chronic Toxicity Testing
Sub-chronic Toxicity Testing
Sub-acute Toxicity Testing
Acute Toxicity Testing
By Toxicity Endpoints
Immunotoxicity
Systemic Toxicity
Carcinogenicity
Genotoxicity
Developmental and Reproductive Toxicity
Other Toxicity Endpoints


By Region:
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Spain
Italy
Rusia
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of MEA

Furthermore, years considered for the study are as follows:

Historical year 2017, 2020
Base year 2021
Forecast period 2022 to 2030.

Target Audience of the Global In-vivo Toxicology Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors